Biochemical and structural studies of Mycobacterium tuberculosis isocitrate lyase

ResearchSpace/Manakin Repository

Show simple item record

dc.contributor.advisor Sperry, J en
dc.contributor.advisor Leung, I en Bhusal, Ram en 2018-10-25T02:52:45Z en 2018 en
dc.identifier.uri en
dc.description.abstract The work described in this Thesis has focused on the study of Mycobacterium tuberculosis isocitrate lyase (ICL), a key enzyme of the glyoxylate cycle. The work included recombinant production and purification of the different ICL isoforms, the development of new biophysical assays to study ICL inhibitors, biochemical and structural studies of ICL isoform 2, and the sustainable synthesis of pharmaceutically important nitrogen-heterocycles using itaconic acid, a weak inhibitor of ICL, as a starting material. The use of the Escherichia coli and Mycobacterium smegmatis expression systems to produce the four isoforms of ICL (isoforms 1, 2, 2a and 2b) was explored. Soluble ICL1, ICL2 and ICL2b were successfully produced and purified. Recombinant ICL2, widely regarded as unstable was found to be a stable enzyme that can be stored in buffers without imidazole. A combined nuclear magnetic resonance (NMR) and thermal shift assay strategy was developed to study ICL inhibitors using ICL1 as a model system. The NMR-based activity assay enables the detection of substrate (isocitrate) consumption and product (succinate) formation in real time, allowing enzyme kinetics and enzyme inhibition to be followed and quantified. It is informative but relatively low throughput. In contrast, the thermal shift assay measures protein stability upon ligand binding. It is an indirect assay but allows the screening of ICL ligands in a high-throughput manner. The effectiveness of this combined strategy was demonstrated by using existing ICL1 inhibitors. Protein X-ray crystallography was used for the structural and biochemical characterisation of ICL2, which was found to be a tetramer. Each monomeric unit contains two distinct domains. Structural and kinetic studies revealed that the C-terminal domain is an acetyl-coenzyme A binding domain. Binding of acetyl-CoA leads to a global conformational change, which leads to the activation of the isocitrate lyase and methylisocitrate lyase activities of ICL2.The synthesis of pharmaceutically important nitrogen-heterocycles using itaconic acid, a weak inhibitor of ICL, was also investigated. A library of diverse N-heterocycles including dihydroindolone, indole, dihydroindolizinone, 2-pyridone, pyrido[1,2-a]indole dihydrocarbazolone and carbazole have been prepared from dimethyl itaconate and pyrrole, two compounds that are readily attainable from biomass. en
dc.publisher ResearchSpace@Auckland en
dc.relation.ispartof PhD Thesis - University of Auckland en
dc.relation.isreferencedby UoA99265114513502091 en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri en
dc.rights.uri en
dc.title Biochemical and structural studies of Mycobacterium tuberculosis isocitrate lyase en
dc.type Thesis en Chemistry en The University of Auckland en Doctoral en PhD en
dc.rights.holder Copyright: The author en
dc.rights.accessrights en
pubs.elements-id 755245 en
pubs.record-created-at-source-date 2018-10-25 en

Full text options

This item appears in the following Collection(s)

Show simple item record Except where otherwise noted, this item's license is described as


Search ResearchSpace

Advanced Search